Ditazole
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C19H20N2O3 |
Molar mass | 324.374 g/mol |
WikiDoc Resources for Ditazole |
Articles |
---|
Most recent articles on Ditazole |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Ditazole at Clinical Trials.gov Clinical Trials on Ditazole at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Ditazole
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Ditazole Risk calculators and risk factors for Ditazole
|
Healthcare Provider Resources |
Causes & Risk Factors for Ditazole |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Ditazole is a platelet aggregation inhibitor.It is marketed in Spain and Portugal under the trade name Ageroplas.[1]
References
- ↑ Martindale's Complete Drug Reference,http://www.medicinescomplete.com/mc/martindale/current/2639-d.htm
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drug
- Cardiovascular Drugs
- Antiplatelet drugs